Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVictrex Regulatory News (VCT)

Share Price Information for Victrex (VCT)

Share Price is delayed by 15 minutes
Get Live Data
609.00    -7.00 (-1.14%)
Bid:
609.00
Ask:
611.00
Spread: 2.00 (0.328%)
Market Cap: £530.59m
VCT Live PriceLast checked at - London Stock Exchange

Intraday Victrex Share Chart

AGM and Interim Management Statement

9 Feb 2010 07:00

RNS Number : 8437G
Victrex PLC
09 February 2010
 



 

 9 February 2010

Victrex plc

 

AGM and Interim Management Statement

 

At the Annual General Meeting of Victrex plc to be held today, Chairman Anita Frew will make the following statement which comprises Victrex's Interim Management Statement covering the period from 1 October 2009 to date:

 

"We are pleased to report that Group sales volume for the four months to the end of January amounted to approximately 714 tonnes consolidating the positive trend in volumes in our Victrex Polymer Solutions ('VPS') business that we indicated in our preliminary results announcement in December. As expected, December sales volumes were lower than the average for the first two months of the financial year, reflecting the normal seasonal trend. However, January sales volumes rebounded and showed further growth over October and November as customers recommenced activity in the New Year. While it remains too early to predict the outcome for the year as a whole, the underlying trends being experienced across VPS are encouraging.

 

Invibio®, our biomaterials business, continues to make good progress following reduced revenue in the second half of last year caused principally by inventory rationalisation. Revenues for the four months to the end of January were at similar levels to the average run rate we achieved in 2009 (annual sales revenue of £34.2m). We remain confident that Invibio revenue for 2010 will show continued growth.

 

The Group remains in a strong financial position with a healthy balance sheet and good cash generation and there have been no significant changes in the financial position of the Company since 30 September 2009."

 

The Company's trading update for the six months to 31 March 2010 will be issued on Thursday 8 April 2010.

 

 

Enquiries

 

Victrex plc

Anita Frew, Chairman 0207 357 9477 (9 February 2010)

David Hummel, Chief Executive 01253 897700 (thereafter)

Mike Peacock, Finance Director

 

Hogarth Partnership Limited

Nick Denton / Barnaby Fry 0207 357 9477

 

 

Victrex plc is an innovative world leader in high performance materials through the manufacture of VICTREX® PEEK™ polymer, a high performance, easy to process thermoplastic.

 

With over 30 years of experience, Victrex is a global manufacturer of innovative, high performance thermoplastic polymers. We work with customers and end users to deliver technology driven solutions to the challenges and opportunities they face. Our Victrex Polymer Solutions division ('VPS') focuses on our transport, industrial and electronics markets and our Invibio Biomaterial Solutions division ('Invibio') focuses on providing specialist solutions for medical device manufacturers.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMZMGGZVRZGGZM
Date   Source Headline
25th Jul 20137:00 amRNSInterim Management Statement
17th Jul 20131:46 pmRNSDirector/PDMR Shareholding
2nd Jul 201310:54 amRNSHolding(s) in Company
2nd Jul 20137:39 amRNSDirector Declaration
28th Jun 20138:00 amRNSTotal Voting Rights
26th Jun 20139:35 amRNSHolding(s) in Company
25th Jun 201310:43 amRNSHolding(s) in Company
24th Jun 20132:33 pmRNSHolding(s) in Company
21st Jun 20139:13 amRNSHolding(s) in Company
18th Jun 20134:41 pmRNSDirector/PDMR Shareholding
7th Jun 201312:26 pmRNSHolding(s) in Company
5th Jun 20132:02 pmRNSDirector/PDMR Shareholding
3rd Jun 20131:50 pmRNSBlocklisting Interim Review
31st May 20131:49 pmRNSTotal Voting Rights
28th May 20139:02 amRNSHolding(s) in Company
28th May 20137:00 amRNSHalf Yearly Report
20th May 20133:34 pmRNSHolding(s) in Company
17th May 20131:39 pmRNSDirector/PDMR Shareholding
16th May 201310:35 amRNSHolding(s) in Company
14th May 20139:58 amRNSHolding(s) in Company
30th Apr 20133:53 pmRNSTotal Voting Rights
24th Apr 20134:24 pmRNSHolding(s) in Company
22nd Apr 20134:14 pmRNSHolding(s) in Company
22nd Apr 20134:02 pmRNSHolding(s) in Company
17th Apr 20131:54 pmRNSDirector/PDMR Shareholding
16th Apr 20134:34 pmRNSHolding(s) in Company
9th Apr 20137:00 amRNSTrading Statement
3rd Apr 20133:01 pmRNSHolding(s) in Company
28th Mar 20133:00 pmRNSTotal Voting Rights
22nd Mar 20139:51 amRNSHolding(s) in Company
21st Mar 201310:25 amRNSHolding(s) in Company
20th Mar 201312:28 pmRNSDirector/PDMR Shareholding
13th Mar 201312:20 pmRNSHolding(s) in Company
28th Feb 20133:19 pmRNSTotal Voting Rights
28th Feb 20132:49 pmRNSDirector/PDMR Shareholding
27th Feb 201311:05 amRNSHolding(s) in Company
26th Feb 20139:32 amRNSHolding(s) in Company
20th Feb 201311:38 amRNSDirector/PDMR Shareholding
5th Feb 20134:24 pmRNSResult of AGM
5th Feb 20137:00 amRNSAGM and Interim Management Statement
4th Feb 201311:42 amRNSHolding(s) in Company
31st Jan 201312:47 pmRNSTotal Voting Rights
29th Jan 201312:46 pmRNSHolding(s) in Company
23rd Jan 201312:23 pmRNSHolding(s) in Company
17th Jan 20134:13 pmRNSDirector/PDMR Shareholding
8th Jan 201310:24 amRNSHolding(s) in Company
7th Jan 20132:40 pmRNSAnnual Information Update
7th Jan 20132:02 pmRNSAnnual Financial Report
7th Jan 201312:37 pmRNSHolding(s) in Company
28th Dec 201212:00 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.